A discussion of the use of beta-blocker therapy following AMI, with Christopher Granger, MD, Gregg Fonarow, MD, and Carlin S ...

For patients with acute myocardial infarction (MI) and anemia, 30-day risks for death or recurrent MI seem to increase with ...

In this secondary analysis of the MINT trial, 30-day risks for the composite outcome of death and recurrent myocardial ...

The following is a summary of “Liberal versus restrictive transfusion strategies in acute myocardial infarction: a systematic review and comparative frequentist and Bayesian meta-analysis of ...

Early use of mechanical circulatory support did not reduce 6-month all-cause mortality. 2. MCS was associated with increased ...

Background New-onset postoperative atrial fibrillation (POAF) after coronary artery bypass grafting (CABG) increases ...

18 The time relations between the onset of myocardial infarction and death have not been adequately studied. Most reviews concerning the immediate prognosis of myocardial infarction lump all ...

The following is a summary of “Bleeding complications, coagulation disorders, and their management in acute myocardial ...

Although the quantitative and serial changes in blood enzymes observed in myocardial infarction are characteristic, they are not specific in that other states such as those of liver, biliary and ...

The FDA has approved Flyrcado™ for positron emission tomography myocardial perfusion imaging under rest or stress in adult patients.

Higher frequency and severity of acute exacerbations of COPD increases the risk for myocardial infarction and pulmonary embolism.

Asamedic and Bormioli Pharma join forces to commercialize Coxor™, a liquid-form heart attack medication, utilizing Bormioli ...